2m 2m 2m 2m 2m 2m 2m
Insmed (INSM)
NASDAQ
$125.95+$0.18 (+0.14%)
Price as of Aug 21, 2026 7:30 PM EDT- $27.5BMarket Cap
- -4.63%1-Year Change
- BiotechnologyIndustry
Insmed (INSM)
$125.95+$0.18 (+0.14%)
INSM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $125.77 | ||
Change | +$0.69 (+0.55%) | ||
Open | $125.22 | ||
High | $127.20 | ||
Low | $124.82 | ||
Previous Close | $125.08 | ||
Volume | 1,124,492 | ||
30-Day Average Volume | 2,926,955 | ||
1-Week Change | 1.64% | ||
1-Month Change | 15.79% | ||
1-Year Change | -4.63% | ||
3-Year Change | 471.68% | ||
5-Year Change | 433.60% | ||
Fundamentals | |||
Shares Outstanding | 218.4M | ||
Total Assets | $2.1B | ||
Market Cap | $27.5B | ||
Enterprise Value | $27.5B | ||
Period: QTR TTM FY | |||
Revenue | $425.5M | ||
Net Income | -$13.2M | ||
Free Cash Flow | -$95.1M | ||
EBIT | -$11.4M | ||
EBITDA | -$9.3M | ||
Net Working Capital | $1.2B | ||
EPS | -$0.06 | ||
Enterprise Value/EBITDA | -2,956 | ||
Enterprise Value/Revenue | 65 | ||
P/B | 36 | ||
P/E | -2,096 | ||
PEG | -23 | ||
Price/Free Cash Flow | -289 | ||
Price/Operating Cash Flow | -309 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 03/03/2011 | ||
Earnings & Revenue